Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Feigh

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 24, 2015
Independent effects of endurance training and weight loss on peak fat oxidation in moderately overweight men: a randomized controlled trialPernille Nordby, Mads Rosenkilde, Thorkil Ploug, et al.
BMC Gastroenterology|December 30, 2019
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASHMaria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, et al.
Hepatology Communications|September 14, 2020
The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic SteatohepatitisNikolaos Perakakis, Aditya Joshi, Natia Peradze, et al.
World Journal of Hepatology|June 22, 2016
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsyMaria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Kristoffer Tobias Gustav Rigbolt, et al.
Plos One|October 28, 2025
The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASHJenny Norlin, Maria Dermit, Nikos Sidiropoulos, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 8, 2014
A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in ratsKim V Andreassen, Michael Feigh, Sara T Hjuler, et al.
Journal of Translational Medicine|November 1, 2012
Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assistAnita V Neutzsky-Wulff, Kim V Andreassen, Sara T Hjuler, et al.
World Journal of Gastroenterology|January 30, 2018
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitisKirstine S Tølbøl, Maria Nb Kristiansen, Henrik H Hansen, et al.
European Journal of Pharmacology|May 27, 2014
Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic ratsMichael Feigh, Sara T Hjuler, Kim V Andreassen, et al.
Molecular Metabolism|December 8, 2023
Evaluation of long acting GLP1R/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1/glucagon agonism in NASH patientsThomas Monfeuga, Jenny Norlin, Anne Bugge, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 24, 2015
Independent effects of endurance training and weight loss on peak fat oxidation in moderately overweight men: a randomized controlled trialPernille Nordby, Mads Rosenkilde, Thorkil Ploug, et al.
BMC Gastroenterology|December 30, 2019
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASHMaria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, et al.
Hepatology Communications|September 14, 2020
The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic SteatohepatitisNikolaos Perakakis, Aditya Joshi, Natia Peradze, et al.
World Journal of Hepatology|June 22, 2016
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsyMaria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Kristoffer Tobias Gustav Rigbolt, et al.
Plos One|October 28, 2025
The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASHJenny Norlin, Maria Dermit, Nikos Sidiropoulos, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 8, 2014
A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in ratsKim V Andreassen, Michael Feigh, Sara T Hjuler, et al.
Journal of Translational Medicine|November 1, 2012
Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assistAnita V Neutzsky-Wulff, Kim V Andreassen, Sara T Hjuler, et al.
World Journal of Gastroenterology|January 30, 2018
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitisKirstine S Tølbøl, Maria Nb Kristiansen, Henrik H Hansen, et al.
European Journal of Pharmacology|May 27, 2014
Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic ratsMichael Feigh, Sara T Hjuler, Kim V Andreassen, et al.
Molecular Metabolism|December 8, 2023
Evaluation of long acting GLP1R/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1/glucagon agonism in NASH patientsThomas Monfeuga, Jenny Norlin, Anne Bugge, et al.
Pageof 5